thats normal inflammation.) But excessive chronic inflammation, which results from an immune system over-policing threats throughout the body, is a leading cause of organ damage, stroke, and neurological problems
The SELECT cardiovascular outcomes trial showed that semaglutide 2.4 mg significantly reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in patients with established cardiovascular disease and overweight or obesity, even without type 2 diabetes
If that history is unremarkable and you have no palpable thyroid abnormalities, standard tirzepatide initiation can proceed without additional thyroid testing
As adoption continues to grow, employers face a challenging question: How do you balance the clinical promise of GLP-1 therapies with their financial impact
Wadden TA, Brown GK, Egebjerg C, Frenkel O, Goldman B, Kushner RF, et al